Purdue Pharma agreed to pay $270 million to the Oklahoma state attorney general on March 26, 2019 for its painkiller medication, OxyContin, for aggressively marketing its drug that led to an epidemic of deaths in the state. The settlement includes money that will establish addiction treatment and research centers and money that will go directly to cities and counties dealing with the opioid crisis. The Oklahoma state attorney general alleged that Purdue’s deceptive marketing of the medication for the last decade led the public into believing that long term use of the opioids was safe. Oklahoma was the first state out of thirty six to be set for trial. However, the drug makers settled with the state attorney general before the jury trial begun.